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Abstract: 
Supplement users (SU) have healthy lifestyle choices; on the other hand, SU report more medical 
conditions.  We hypothesised that cod liver oil (CLO) consumers are similar to non-supplement 
users, since CLO use might originate from historical motives, i.e. rickets prevention, and not 
health consciousness.  CLO consumers were studied in order to identify possible confounders, 
such as confounding by indication. The European Prospective Investigation into Cancer (EPIC) 
investigates causes of chronic disease.  The participants were 25,639 men and women, aged 
40-79 year, recruited from general practices in Norfolk, East-Anglia (UK).  Participants 
completed questionnaires and a health examination between 1993 and 1998.  Supplement use 
was measured using 7-day diet diaries.  CLO was the most common supplement used, more 
prevalent among women and associated with not smoking, higher physical activity level and 
more favourable eating habits.  SU had a higher occurrence of benign growths and bone-related 
diseases, but CLO was negatively associated with cardiovascular-related conditions. Although 
the results of SU characteristics in EPIC-Norfolk are comparable with studies worldwide, the 
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CLO group is different from SU in general.  Confounding by indication takes place and will need 
to be taken into account when analysing prospective associations of CLO use with fracture risk 
and cardiovascular diseases. 
 
 
Keywords: dietary supplement; cod liver oil; socio-demographics; health; confounding; 
cardiovascular disease 
 
1. Introduction 
Since the 19
th
 century, cod liver (CLO), for its source of vitamin D, has been used as one of the 
remedies to cure rickets [1].  It has been the most commonly used supplement in the UK for decades 
[2–6].  In EPIC-Norfolk, 32% of men and 45% of women used dietary supplements between 1993 and 
1998 [7] with nearly 25% of all participants consuming CLO [8].  Special interest in CLO supplement 
use is warranted for several reasons.  Firstly, for its nutrients, CLO contains eicosapentaenoic acid and 
docosahexaenoic acid, which in observational studies have been negatively associated with several 
cancer sites [9,10]; on the other hand, meta-analyses of trial and/or cohort data have shown no effect of 
these omega-3 fatty acids in supplement form on cardiovascular disease [11,12].  CLO also provides 
vitamins A, D and E of which vitamin D prevents osteomalacia and has been associated with 
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osteoporosis [13]; while chronic intake above 1500 µg/d of vitamin A might increase the risk of 
fractures [14].  Secondly, methodological reasons: there is no such person as ‘a supplement user’ 
[5,15], supplement users (SU) are heterogeneous and ignoring these differences can lead to bias [16].  
These differences are not only due to lifestyle [17], but also to what is referred to as ‘confounding by 
indication’ [5,18,19].  Meaning that certain co-morbidities make the use of certain dietary supplements 
more likely, which, if not taken into account, could lead to the conclusion that there is an association 
between the exposure, i.e. dietary supplements, and outcome (e.g. fracture) when in fact the 
co-morbidity (e.g. osteoporosis) is merely an indication for, or increases, supplement use. 
Before public health messages can be formulated to encourage or discourage CLO use, also in the 
light of possible harmful effects when overdosed [20], a careful analysis of eating habits and other 
possible confounders in CLO consumers will have to precede this [16].  Supplement use in general in 
the United Kingdom [3–5,21], Europe [22], the United States [23] and Australia [24,25] has been 
associated with socio-demographic factors such as being a woman, being older, having a higher 
socio-economic status; behaviour-wise, SU exercise more, smoke less, eat more healthily and have a 
lower body mass index (BMI).  Whether CLO consumers share the same characteristics as SU in 
general, and as a result would confound the association found between CLO consumption and health, 
requires further study.  The high proportion of CLO consumers, as well as the detailed information 
collected in this aging cohort, puts EPIC-Norfolk in a position to study such associations. 
This paper describes the socio-demographics, eating habits, anthropometry and self-reported health 
of NSU and SU in EPIC-Norfolk, with a special focus on the most commonly consumed supplement: 
CLO. 
2. Methods  
2.1. Study design and participant selection  
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and 
all procedures were approved by the Norfolk District Health Authority Ethics Committee.  Written 
informed consent was obtained from all participants.  The study started in 1993 with participants aged 
between 40 and 79 years.  Participants lived in the Norfolk area of East Anglia and were recruited from 
general practitioners’ (GP) age-sex registers [26].  Of the 77,630 invited participants, 30,447 gave their 
informed consent and received a Health and Lifestyle Questionnaire.  Of this group, 25,639 attended a 
health examination at their GP-clinic and were given a 7-day Diet Diary (7dDD). 
2.2. Data collection 
The Health and lifestyle Questionnaire was sent to the participants in advance of their GP clinic 
appointment.  Participants were asked about the following: smoking habits (never, former or current 
smoker); final level of education obtained (no qualifications, O-level, A-level, Degree or equivalent); 
current profession, from which socio-economic class was derived (unskilled, semi-skilled, skilled 
manual, skilled non-manual, managerial or professional); marital status (married, single, widowed, 
divorced or separated); a validated physical activity score combining occupational and recreational 
physical activity (active, moderately active, moderately inactive, inactive) [27]; and self-reported 
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illnesses, such as cardiovascular diseases, diabetes, cancer and osteoporosis, measured by the question: 
“Has the doctor ever told you that you have any of the following”.  The participant’s postcode was 
linked to the Townsend residential area deprivation score.  This score identifies material deprivation by 
using four components: unemployment, non-car ownership, non-house ownership and overcrowding, 
i.e. the number of people who live per room in a house [28]. 
Participants were taken through the research protocol by a trained nurse [26].  During the health 
examination, weight (kg) and height (cm) were measured from which Body Mass Index (BMI) was 
calculated (kg/m2). 
A 7dDD was handed out at the health examination [29,30].  This diary was a 45-page, A5 booklet, 
with detailed instructions regarding how food and drink should be recorded, as well as seventeen series 
of colour photos, depicting portions of food items on plates in increasing quantities.  The nurse 
completed a 24-hour diet recall as a means of instruction (n=25,507; 99%).  The remainder of the 
7dDD was completed at the participant’s home, 23,638 (92%) of the participants completed more than 
one day. 
The 7dDD ended with general questions, referred to as the ‘Back Of Diary (BOD)’, and was 
completed by 23,309 (91%) participants [8].  The BOD included the question relating to supplement 
use (“Please name any vitamins, minerals or other food supplements taken on each day of last week”).  
If this question was left open, crossed out or answered with ‘no/none’, then participants were 
categorised as NSU; however, if participants had recorded any supplements taken, they were 
categorised as SU.  Kappa-statistics with instruments recalling supplement use over the past year in 
EPIC-Norfolk ranged from 0.72-0.78 [7].  Supplements were coded according to the Vitamin and 
Minerals Supplement (ViMiS) system described in detail elsewhere [8].  Summarised, supplements 
were grouped into 45 distinct groups of which CLO was one.  This group included CLO or any other 
type of fish oil, and CLO supplements combined with multivitamins or with, for example, evening 
primrose oil in the same capsule.  For the purpose of this analysis, participants who reported 
medication containing vitamins and/or minerals without further supplement use were classified as 
NSU. 
The 7dDD were entered by trained data-entry clerks using a program called DINER, Data Into 
Nutrients for Epidemiological Research [30] and checked and calculated by nutritionists using 
DINERMO [31].  Alcohol intake in grams was divided by 8 to obtain the number of units in alcoholic 
beverages.  Food group data were calculated by summing the weight of each food item consumed, 
belonging to either fruit, vegetables, red, white or processed meat or white and fatty fish, as well as the 
percentage contribution to these food groups from composite food items (e.g. Beef stew including 
vegetables) [31].  These food groups were chosen because of established associations with cancer and 
cardiovascular risk factors [32]. 
2.3. Statistical analysis  
The characteristics of participants were compared using two different groupings.  First, NSU vs. 
SU, followed by two SU subgroups in order to elucidate possible confounding factors for CLO users: 
SU+CLO, participants who used CLO or supplements where cod liver oil/fish oil was an ingredient, 
also when used in combination with non-CLO supplements (i.e. multiple supplement users of which at 
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least one contained CLO); SU-CLO, participants who consumed one or more supplements that did not 
contain CLO. 
Both comparisons were firstly carried out without adjustment, stratified by sex, using the 
Chi-squared statistic, followed by multivariable binary (SU vs. NSU) and multinomial (SU+CLO vs. 
NSU and SU-CLO vs. NSU) logistic regression to compare these groups adjusted for all presented 
socio-demographic variables. 
Differences in food consumption between NSU and SU groups were tested using the 
Mann-Whitney U and Kruskal-Wallis statistic.  Associations between self-reported illnesses and 
supplement use were adjusted for age using multinomial logistic regression, with supplement use as 
the dependent variable (NSU/SU+CLO/SU-CLO).  Analyses were performed using IBM SPSS v19.  
P-values below 0.05 were considered significant. 
3. Results  
3.1. Supplement consumption  
Out of 23,039 participants who answered the BOD, 3,253 (31.7%) of men (n=10,247) and 5,736 
(44.8%) of women (n=12,792) used a supplement (χ2 (1)=410.01, P<0.001).  A total of 5,262 and 
10,732 supplements were consumed by men and women respectively.  For both men and women, CLO 
was the most commonly consumed supplement (43% and 32% respectively), followed by garlic (12%) 
and multivitamins (11%) for men and multivitamins (11%) and evening primrose oil (10%) for 
women.  For CLO supplements, 94% of men and 96% of women used these on a daily basis compared 
to 89% and 90% respectively for non-CLO supplements.  CLO supplements were consumed by 22% 
of men and 26% of women.  Only 10% of men consumed supplements that did not contain CLO, 
compared to 19% of women. 
3.2. Socio-demographic characteristics of supplement users  
Supplement use in general was associated with sex-dependent characteristics (see columns NSU 
and SU in Table 1 for men and Table 2 for women).  Male SU were older than NSU, whereas female 
SU completed higher levels of education than female NSU.  Marital status was not, and Townsend 
score only weakly, associated with supplement use.  All other characteristics had, in general, stronger 
associations among women compared to men.  In summary, supplement use indicated a healthier 
lifestyle and higher socio-economic class. 
The characteristics of the participants who consumed a supplement that contained CLO (SU+CLO) 
vs. NSU and participants who consumed other types of supplements (SU-CLO) vs. NSU (see Table 1 
and Table 2), resulted in stronger associations with socio-demographic characteristics with supplement 
use, especially among women.  Notably, younger age in women was strongly associated with the SU-
CLO category, similarly for higher education level; however, such associations among SU+CLO were 
not present.  In men, not being married as well as a higher education level, though not associated with 
supplement use in general, was associated with SU-CLO. 
 
Table 1: Characteristics of EPIC-Norfolk participants (men only) according to supplement status (NSU/SU) and supplement subgroup (NSU/SU+CLO/SU-CLO).  Analysis are shown 
unadjusted (Chi-squared test).  Logistic regression (NSU/SU) and multinomial logistic regression (NSU/SU+CLO/SU-CLO) were adjusted for all variables in this table (n=9,943).  
Boldly printed OR were statistically significant findings. 
MEN NSU 
N 
 
% 
SU 
N 
 
% 
SU+CLO 
N 
 
% 
SU-CLO 
N 
 
% 
SU vs. NSU 
OR 
 
95% CI 
SU+CLO vs. NSU 
OR 
 
95% CI 
SU-CLO vs. NSU 
OR 
 
95% CI 
Age 6,994  3,253  2,215  1,038        
<=50 yrs 1,696 24.2 528 16.2 285 12.9 243 23.4 1.15 1.12-1.18 1.21 1.17-1.24 1.05 1.01-1.09 
>50-60 yrs 2,199 31.4 950 29.2 649 29.3 301 29.0 OR represents the % change in odds of being 
>60-70 yrs 2,120 30.3 1,218 37.4 876 39.5 342 32.9 a SU for every 5 year increment in age 
>70 yrs 979 14.0 557 17.1 405 18.3 152 14.6  
 χ 2 (3)=118.51, P<0.001 χ 2 (6)=170.43, P<0.001        
               
Marital status 6,967  3,227  2,198  1,029        
Married 6,110 87.7 2,839 88.0 1,956 89.0 883 85.8 Ref  Ref  Ref  
Not marrieda 857 12.3 388 12.0 242 11.0 146 14.2 1.01 0.88-1.15 0.88 0.75-1.03 1.30 1.07-1.58 
 χ 2 (1)=0.16, n.s. χ 2 (2)=6.76, P<0.05        
               
Social class 6,881  3,197  2,174  1,023        
Non-Manualb 3,935 57.2 1,961 61.3 1,265 58.2 696 68.0 Ref  Ref  Ref  
Manualc 2,946 42.8 1,236 38.7 909 41.8 327 32.0 0.87 0.79-0.95 1.00 0.90-1.11 0.63 0.55-0.74 
 χ 2 (1)=15.50, P<0.001 χ 2 (2)=43.29, P<0.001        
               
Education level 6,991  3,249  2,211  1,038        
Any qualificationd 4,829 69.1 2,276 70.1 1,508 68.2 768 74.0 Ref  Ref  Ref  
No qualifications 2,162 30.9 973 29.9 703 31.8 270 26.0 0.93 0.84-1.03 0.95 0.84-1.06 0.89 0.76-1.05 
 χ 2 (1)=1.00, n.s. χ 2 (2)=12.12, P<0.01        
               
Townsend indexe 6,968  3,245  2,211  1,034        
Score <0 5,859 84.1 2,786 85.9 1,910 86.4 876 84.7 Ref  Ref  Ref  
Score >0 1,109 15.9 459 14.1 301 13.6 158 15.3 0.93 0.82-1.05 0.88 0.76-1.02 1.04 0.86-1.26 
 χ 2 (1)=5.34, P<0.05 χ 2 (2)=6.85, P<0.05        
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MEN NSU 
N 
 
% 
SU 
N 
 
% 
SU+CLO 
N 
 
% 
SU-CLO 
N 
 
% 
SU vs. NSU 
OR 
 
95% CI 
SU+CLO vs. NSU 
OR 
 
95% CI 
SU-CLO vs. NSU 
OR 
 
95% CI 
Smoking 6,951  3,226  2,197  1,029        
Never 2,295 33.0 1,111 34.4 730 33.2 381 37.0 Ref  Ref  Ref  
Former 3,756 54.0 1,872 58.0 1,309 59.6 563 54.7 0.95 0.87-1.05 0.97 0.87-1.08 0.91 0.79-1.05 
Current 900 12.9 243 7.5 158 7.2 85 8.3 0.59 0.50-0.69 0.58 0.48-0.70 0.61 0.47-0.79 
 χ 2 (2)=65.22, P<0.001 χ 2 (4)=71.95, P<0.001        
               
Physical activityf 6,991  3,249  2,211  1,038        
(Moderately) active 3,060 43.8 1,475 45.4 1,000 45.2 475 45.8 Ref  Ref  Ref  
(Moderately) inactive 3,931 56.2 1,774 54.6 1,211 54.8 563 54.2 0.82 0.75-0.90 0.82 0.74-0.91 0.81 0.71-0.93 
 χ 2 (1)=2.38, n.s. χ 2 (2)=2.46, n.s.        
               
Start 7dDDg 6,994  3,252  2215  1,037        
Spring/Summer 3,507 50.1 1,541 47.4 1,066 48.1 475 45.8 Ref  Ref  Ref  
Autumn/Winter 3,487 49.9 1,711 52.6 1,149 51.9 562 54.2 1.12 1.03-1.22 1.09 0.98-1.20 1.20 1.05-1.37 
 χ 2 (1)=6.75, P<0.01 χ 2 (2)=8,27, P<0.05        
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ 2, Chi-squared test; OR, odds ratio, CI, confidence interval. 
a
 Not married included the categories (NSU/SU): single (n=290/128), widowed (n=213/106), separated (n=69/19) and divorced (n=286/135). 
b
 Non-manual included the categories (NSU/SU): professional (n=544/222), managerial (n=2,531/1,315), skilled non-manual (n=860/424). 
c
 Manual included the categories (NSU/SU): skilled manual (n=1,787/760), semi-skilled (n=934/397) and non-skilled (n=225/79). 
d
 Any qualification included (NSU/SU): O-level (n=587/291), A-level (n=3,177/1,518), Degree or equivalent (n=1,065/467). 
e
 Townsend index score < 0 means district in which the participant lives is more affluent than the mean in England; score > 0 means a district in which the 
participant lives is more deprived than the mean in England. 
f
 Included the categories (NSU/SU): active (1467/705), moderately active (1593/770), moderately inactive (1685/837), inactive (2246/937). 
g
 Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February. 
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Table 2: Characteristics of EPIC-Norfolk participants (women only) according to supplement status (NSU/SU) and supplement subgroup (NSU/SU+CLO/SU-CLO).  Analysis are 
shown unadjusted (Chi-squared test).  Logistic regression (NSU/SU) and multinomial logistic regression (NSU/SU+CLO/SU-CLO) were adjusted for all variables in this table 
(n=12,262).  Boldly printed OR were statistically significant findings. 
WOMEN NSU 
N 
 
% 
SU 
N 
 
% 
SU+CLO 
N 
 
% 
SU-CLO 
N 
 
% 
SU vs. NSU 
OR 
 
95% CI 
SU+CLO vs. NSU 
OR 
 
95% CI 
SU-CLO vs. NSU 
OR 
 
95% CI 
Age 7,056  5,736  3,389  2,347        
<=50 yrs 1,833 26.0 1,356 23.6 611 18.0 745 31.7 1.02 1.00-1.04 1.09 1.06-1.12 0.93 0.90-0.95 
>50-60 yrs 2,185 31.0 1,862 32.5 1,107 32.7 755 32.2 OR represents the % change in odds of being 
>60-70 yrs 2,100 29.8 1,792 31.2 1,170 34.5 622 26.5 a SU for every 5 year increment in age 
>70 yrs 938 13.3 726 12.7 501 14.8 225 9.6       
 χ 2 (3)=12.43, P<0.01 χ 2 (6)=175.26, P<0.001        
               
Marital status 7,025  5,691  3,363  2,328        
Married 5,400 76.9 4,315 75.8 2,519 74.9 1,796 77.1 Ref  Ref  Ref  
Not marrieda 1,625 23.1 1,376 24.2 844 25.1 532 22.9 1.06 0.98-1.16 1.06 0.96-1.17 1.06 0.94-1.20 
 χ 2 (1)=1.91, n.s. χ 2 (2)=5.75, n.s.        
               
Social class 6,865  5,612  3,299  2,313        
Non-Manualb 4,063 59.2 3,610 64.3 2,049 62.1 1,561 67.5 Ref  Ref  Ref  
Manualc 2,802 40.8 2,002 35.7 1,250 37.9 752 32.5 0.84 0.78-0.91 0.90 0.82-0.99 0.76 0.69-0.85 
 χ 2 (1)=34.48, P<0.001 χ 2 (2)=51.09, P<0.001        
               
Education level 7,052  5,732  3,386  2,346        
Any qualificationd 3,942 55.9 3,423 59.7 1,869 55.2 1,554 66.2 Ref  Ref  Ref  
No qualifications 3,110 44.1 2,309 40.3 1,517 44.8 792 33.8 0.91 0.84-0.99 1.02 0.93-1.11 0.77 0.69-0.86 
 χ 2 (1)=18.88, P<0.001 χ 2 (2)=88.08, P<0.001        
               
Townsend indexe 7,030  5,710  3,375  2,335        
Score <0 5,845 83.1 4,845 84.9 2,851 84.5 1,994 85.4 Ref  Ref  Ref  
Score >0 1,185 16.9 865 15.1 524 15.5 341 14.6 0.91 0.82-1.01 0.91 0.81-1.02 0.91 0.80-1.05 
 χ 2 (1)=6.80, P<0.01 χ 2 (2)=7.67, P<0.05        
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WOMEN NSU 
N 
 
% 
SU 
N 
 
% 
SU+CLO 
N 
 
% 
SU-CLO 
N 
 
% 
SU vs. NSU 
OR 
 
95% CI 
SU+CLO vs. NSU 
OR 
 
95% CI 
SU-CLO vs. NSU 
OR 
 
95% CI 
Smoking 6,992  5,680  3,350  2,330        
Never 3.949 56.5 3,260 57.4 1,939 57.9 1,321 56.7 Ref  Ref  Ref  
Former 2,179 31.2 1,930 34.0 1,162 34.7 768 33.0 1.08 1.00-1.17 1.07 0.98-1.17 1.09 0.98-1.21 
Current 864 12.4 490 8.6 249 7.4 24 10.3 0.71 0.63-0.80 0.61 0.53-0.72 0.85 0.72-0.99 
 χ 2 (2)=48.93, P<0.001 χ 2 (4)=61.43, P<0.001        
               
Physical activity f 7,052  5,732  3,386  2,346        
(Moderately) active 2,561 36.3 2,259 39.4 1,282 37.9 977 41.6 Ref  Ref  Ref  
(Moderately) inactive 4,491 63.7 3,473 60.6 2,104 62.1 1,369 58.4 0.87 0.80-0.94 0.87 0.80-0.96 0.86 0.77-0.95 
 χ 2 (1)=12.89, P<0.001 χ 2 (2)=21.34, P<0.001        
               
Start 7dDDg 7,056  5,736  3,389  2,347        
Spring/Summer 3,662 51.9 2,765 48.2 1,640 48.4 1,125 47.9 Ref  Ref  Ref  
Autumn/Winter 3,394 48.1 2,971 51.8 1,749 51.6 1,222 52.1 1.16 1.08-1.25 1.15 1.06-1.26 1.17 1.07-1.29 
 χ 2 (1)=17.28, P<0.001 χ 2 (2)=17.39, P<0.001        
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ 2, Chi-squared test. 
a
 Not married includes the categories (NSU/SU): single (n=281/230), widowed (n=806/670), separated (n=67/65) and divorced (n=471/411). 
b
 Non-manual includes the categories (NSU/SU): professional (n=421/372), managerial (n=2,343/2,026), skilled non-manual (n=1,299/1,212). 
c
 Manual includes the categories (NSU/SU): skilled manual (n=1,511/1,115), semi-skilled (n=971/702) and non-skilled (n=320/185). 
d
 Any qualification included (NSU/SU): O-level (n=830/640), A-level (n=2,363/2,163), Degree or equivalent (n=749/620). 
e
 Townsend index score < 0 means district in which the participant lives is more affluent than the mean in England; score > 0 means a district in which the 
participant lives is more deprived than the mean in England. 
f
 Included the categories (NSU/SU): active (1012/954), moderately active (1549/1305), moderately inactive (2186/1924), inactive (2305/1549). 
 g
 Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February. 
Results of the fully adjusted analysis (NSU vs. SU) are to be found in Table 1 and Table 2 (see 
column SU vs. NSU).  3.6% of the participants were lost due to missing values for one or more 
variables (N=22,205).  For supplement use in general, results remained the same as in the unadjusted 
analysis, except for the area deprivation score in both sexes.  Smoking had the strongest association 
with supplement use, decreasing the odds of supplement use with 41% in men and 29% in women; 
followed by physical inactivity in men and winter season and lower social class in women.  The 
analysis was repeated with sex in the model (data not shown) and showed a significant independent 
effect of sex on supplement use in general (OR=0.54; 95%CI: 0.51-0.58). 
Multinomial logistic regression compared NSU with the two SU subgroups (SU+CLO and 
SU-CLO, see last two columns in Table 1 and Table 2).  Results were similar compared to the 
unadjusted analysis, with exception of education level among men and area deprivation score in both 
sexes, which lost their significance.  Strongest associations were again seen for current smoking; other 
variables, particularly social class and education, were more strongly associated with the SU-CLO 
group and not with the SU+CLO group when compared to supplement use in general. 
3.3. Food choices of supplement users  
SU in general consumed significantly more fruit, vegetables and fatty fish and less red and 
processed meat than NSU (Table 3).  In both men and women, the lower intake of red and processed 
meats amongst SU in general appeared to be mainly driven by the SU-CLO group, which had a 
significantly lower intake compared to the SU+CLO group (P<0.025).  Although there were no 
associations between alcohol consumption and supplement use in men, we observed a higher 
proportion of alcohol consumers among women using supplements, particularly the SU-CLO group, as 
well as an increment in their median weekly intake (P<0.025). 
3.4. Health and supplement use 
BMI was associated with both age and supplement use.  The mean (95% CI), age-adjusted BMI for 
male NSU was 26.6 (26.5-26.7) kg/m
2
, for SU+CLO 26.3 (26.2-26.4) kg/m
2
 and for SU-CLO 26.1 
(25.9-26.2) kg/m
2
 (F=15.6 [2;10217], P<0.001).  Among women, the association between supplement 
use and BMI was stronger; the mean BMI for female NSU was 26.4 (26.3-26.5) kg/m
2
, for SU+CLO 
25.9 (25.7-26.0) kg/m
2
 and for SU-CLO 25.6 (25.4-25.8) kg/m
2
 (F=42.4 [2;12750], P<0.001). 
In this cross-sectional study, the use of different types of dietary supplements was associated with 
self-reported illnesses (Table 4).  For participants who reported having had benign growths, the odds of 
being a SU-CLO increased by 36% in men and 35% in women compared to NSU.  Diseases affecting 
the heart and circulation were negatively associated with CLO supplement use and not associated with 
non-CLO supplement use.  Men who reported having had a heart attack had a 42% lower odds of using 
CLO compared to men free of a prevalent heart attack; women who reported having been diagnosed 
with diabetes had a 50% reduced odds of being a SU+CLO.  Participants who reported diseases that 
affect bone health were reporting more supplement use.  Women who reported arthritis had a 60% 
increased odds of using CLO and 15% increased use of other types of supplements; similar results for 
CLO use were found for men.  Women who reported osteoporosis had a 58% increased odds of using a 
non-CLO supplement. 
 
Table 3: Comparison of food group intake distributions between Non-Supplement Users and Supplement Users (NSU/SU) and between SU subgroups (NSU/SU+CLO/SU-CLO) in the 
EPIC-Norfolk study. 
 NSU 
Median 
 
IQR 
SU 
Median 
 
IQR 
SU+CLO 
Median 
 
IQR 
SU-CLO 
Median 
 
IQR 
P-value a 
NSU vs. SU 
P-value b 
NSU 
vs. SU+CLO 
vs. SU-CLO 
MEN (n) 6,994  3,252  2,215  1,037    
Fruit (g/d) 127 60-212 161 86-253 161 89-257 158 79-244 P<0.001 P<0.001 
Vegetables (g/d) 139 99-188 145 106-198 146 108-197 145 102-202 P<0.001 P<0.001 
Meat           
Red (g/d) 38 20-59 33 16-54 *34 16-55 31 14-52 P<0.001 P<0.001 
White (g/d) 22 7-40 22 7-40 22 8-40 21 6-40 n.s. n.s. 
Processed (g/d) 25 13-40 22 11-37 *23 12-38 21 9-35 P<0.001 P<0.001 
Fish           
White(g/d) 16 0-25 16 0-27 16 0-27 15 0-27 P<0.01 P<0.01 
Fatty (g/d) 1 0-19 8 0-24 7 0-24 8 0-24 P<0.001 P<0.001 
Alcoholic beverages (units/diary) 8.1 1.2-21.0 8.2 1.2-21.1 8.1 1.3-20.9 8.4 0.9-21.8 n.s. n.s. 
Alcohol consumers only (units/diary) c 13.0 5.3-25.5 13.0 5.4-25.5 12.8 5.1-25.1 13.9 6.0-26.8 n.s. n.s. 
           
WOMEN (n) 7,056  5,736  3,389  2,347    
Fruit (g/d) 151 83-238 180 107-267 *183 110-269 174 104-263 P<0.001 P<0.001 
Vegetables (g/d) 136 97-183 145 107-194 145 108-192 146 105-197 P<0.001 P<0.001 
Meat           
Red (g/d) 27 12-45 24 9-41 *25 10-42 23 7-40 P<0.001 P<0.001 
White (g/d) 18 5-34 19 6-35 19 5-36 19 6-35 P<0.05 n.s. 
Processed (g/d) 16 7-27 14 6-25 *15 6-25 14 4-24 P<0.001 P<0.001 
Fish           
White (g/d) 12 0-21 12 0-22 *13 0-23 11 0-21 n.s. P<0.001 
Fatty (g/d) 3 0-16 6 0-20 6 0-21 6 0-19 P<0.001 P<0.001 
Alcoholic beverages (units/diary) 2.1 0.0-9.2 3.3 0-10.3 *3.1 0.0-9.8 3.9 0.0-11.2 P<0.001 P<0.001 
Alcohol consumers only (units/diary) d 6.9 3.0-14.6 7.3 3.3-14.7 *7.0 3.2-14.1 7.7 3.5-15.2 n.s. P<0.05 
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; IQR, Inter Quartile Range. 
a
 Differences between groups tested using Mann-Whitney U test 
b
 Differences between groups tested using Kruskal-Wallis test and if significant, followed by Mann-Whitney U test to test for differences in SU 
subgroups.  P-values <0.025 were considered significant (Bonferroni correction applied: 0.05/2, marked with an * in the SU+CLO column). 
c 
Men: NSU n=5,411 (77%), SU+CLO n=1,748 (79%), SU-CLO n=799 (77%) 
d 
Women: NSU n=4,352 (62%) , SU+CLO n=2,233 (66%), SU-CLO n=1,611 (69%) 
* P-value < 0.025 (see also footnote b) 
 
Table 4: Differences in self-reported health between non-supplement users (NSU) and supplement user subgroups (SU+CLO, SU-CLO) in EPIC-Norfolk. 
   
N 
 
% 
NSU 
N 
 
% 
SU+CLO 
N 
 
% 
SU-CLO 
N 
 
% 
SU+CLO vs NSU 
OR a 
 
95% C.I. 
SU-CLO vs. NSU 
OR a 
 
95% C.I. 
MEN  10,247  6,994 68.3 2,215 21.6 1,038 10.1     
Mean age (SD)    58.9 9.3 61.8 8.6 59.4 9.3 1.19 1.16-1.22 1.03 0.99-1.07 
Benign growth Yes 993 9.7 634 9.1 234 10.6 125 12.1 1.12 0.96-1.32 1.36 1.11-1.67 
 No 9,235 90.3 6,348 90.9 1,975 89.4 912 87.9 Ref  Ref  
Cancer Yes 405 4.0 259 3.7 94 4.3 52 5.0 0.98 0.76-1.24 1.33 0.98-1.89 
 No 9,830 96.0 6,727 96.3 2,117 95.7 986 95.0 Ref  Ref  
Heart attack Yes 560 5.5 409 5.9 94 4.3 57 5.5 0.58 0.46-0.74 0.90 0.68-1.20 
 No 9,668 94.5 6,573 94.1 2,116 95.7 979 94.5 Ref  Ref  
Stroke Yes 189 1.8 139 2.0 36 1.6 14 1.4 0.65 0.45-0.94 0.64 0.37-1.12 
 No 10,041 98.2 6,846 98.0 2,173 98.4 1,022 98.6 Ref  Ref  
High blood pressure Yes 1,469 14.4 979 14.0 328 14.9 162 15.6 0.92 0.80-1.05 1.11 0.92-1.33 
 No 8,753 85.6 5,999 86.0 1,879 85.1 875 84.4 Ref  Ref  
Diabetes Yes 333 3.3 236 3.4 69 3.1 28 2.7 0.78 0.59-1.03 0.77 0.52-1.14 
 No 9,898 96.7 6,747 96.6 2,141 96.9 1,010 97.3 Ref  Ref  
Arthritis Yes 1,932 18.9 1,137 16.3 604 27.4 191 18.5 1.72 1.53-1.93 1.14 0.96-1.35 
 No 8,282 81.1 5,837 83.7 1,602 72.6 843 81.5 Ref  Ref  
Osteoporosis Yes 60 0.6 42 0.6 12 0.5 6 0.6 0.75 0.39-1.43 0.93 0.39-2.19 
 No 10,166 99.4 6,940 99.4 2,194 99.5 1,032 99.4 Ref  Ref  
              
WOMEN  12,792  7,056 55.2 3,389 26.5 18.3 2,347     
Mean age (SD)    58.6 9.4 60.0 8.8 56.9 9.2 1.09 1.07-1.12 0.91 0.88-0.93 
Benign growth Yes 2,448 19.2 1,227 17.4 703 20.8 518 22.1 1.25 1.12-1.38 1.35 1.21-1.52 
 No 10,304 80.8 5,812 82.6 2,671 79.2 1,821 77.9 Ref  Ref  
Cancer Yes 883 6.9 468 6.6 258 7.6 157 6.7 1.11 0.94-1.30 1.07 0.89-1.30 
 No 11,898 93.1 6,582 93.4 3,127 92.4 2,189 93.3 Ref  Ref  
Heart attack Yes 168 1.3 105 1.5 39 1.2 24 1.0 0.66 0.46-0.96 0.82 0.52-1.28 
 No 12,608 98.7 6,941 98.5 3,345 98.8 2,322 99.0 Ref  Ref  
Stroke Yes 127 1.0 86 1.2 26 0.8 15 0.6 0.55 0.35-0.86 0.61 0.35-1.06 
 No 12,651 99.0 6,962 98.8 3,358 99.2 2,331 99.4 Ref  Ref  
High blood pressure Yes 1,840 14.4 1,067 15.1 483 14.3 290 12.4 0.84 0.74-0.94 0.89 0.77-1.03 
 No 10,926 85.6 5,977 84.9 2,899 85.7 2,050 87.6 Ref  Ref  
Diabetes Yes 205 1.6 139 2.0 37 1.1  29  1.2 0.50 0.35-0.73 0.69 0.46-1.03 
 No 12,571 98.4 6,908 98.0 3,347 98.9 2,316 98.8 Ref  Ref  
Arthritis Yes 3,495 27.4 1,717 24.4 1,195 35.4 583 25.0 1.60 1.46-1.76 1.15 1.03-1.28 
 No 9,247 72.6 5,316 75.6 2,180 65.6 1,751 75.0 Ref  Ref  
Osteoporosis Yes 340 2.7 164 2.3 100 3.0 76 3.2 1.17 0.91-1.51 1.58 1.20-2.09 
 No 12,418 97.3 6,877 97.7 3,276 97.0 2,265 96.8 Ref  Ref  
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; OR, odds ratio, CI, confidence interval. 
a
 Age-adjusted OR (per 5 year) using multinomial logistic regression.  Boldly printed OR were statistically significant findings. 
4. Discussion  
Supplement use in EPIC-Norfolk is more prevalent among women and is associated with not 
smoking, a higher social class, higher physical activity levels and more favourable eating habits.  
These SU characteristics were found to be stronger for subgroups of SU, than for SU in general.  
Moreover, a participant’s self-report of medical conditions at baseline was associated with subgroups 
of supplements, with CLO supplements being strongly positively associated with arthritis and 
negatively associated with cardiovascular conditions. 
The associations found between supplement use in general and socio-demographic variables are in 
line with previous findings from a UK survey and cohort studies [4,5,21].  Our finding of more and 
stronger associations in women compared to men, has also been observed in the MRC National Survey 
of Health and Development [4].  However, important socio-demographic differences exist within SU.  
For example, in our study social class appeared to be mainly associated with SU-CLO use in men and 
women’s education was only associated with SU-CLO use and not SU+CLO use.  Also, while most 
‘unhealthy behaviours’ were less prevalent among SU, exceptions were smoking and alcohol 
consumption among women in the SU-CLO group.  The Norwegian Women and Cancer (NoWAC) 
study grouped participants into categories by frequency of consumption of CLO use [33].  Their 
average age of 45 years was 15 years lower than in EPIC-Norfolk; even so, participants’ age was 
positively associated with daily CLO consumption, as well as being an ex-smoker and being more 
physically active.  Again, this stresses the different possible confounders within subgroups of SU. 
In EPIC-Norfolk, SU, particularly the SU+CLO group, were found to have a higher consumption of 
fruit, vegetables and fatty fish and especially the SU-CLO group had a lower consumption of red and 
processed meat compared to NSU.  These associations are comparable with other studies [4,5,21,33] 
and are indicative that SU are a group of people who are least likely to need supplements.  Although 
SU have in general been characterised as ‘healthy eating’ consumers, this might not necessarily be so 
[15,34].  A longitudinal study in Switzerland found that 21% of daily/weekly vitamin and mineral SU 
were clustered around a ‘healthy’ food pattern (16% among NSU); whereas 31% of daily/weekly 
vitamin and mineral SU consumed an ‘unhealthy’ food pattern (compared to 39% in NSU); the SU 
were also found to have the most positive attitude towards fortification and could have used 
supplements as a means of compensation.  In the current analysis, only a limited set of foods were 
compared between NSU and SU in order to avoid multiple testing, but future analyses could compare 
clusters of a greater variety of foods. 
In this cross-sectional analysis, participants who reported having had benign growths were more 
likely to report non-CLO supplement use.  Cancer was not associated with supplement use in the 
EPIC-Norfolk study, contrary to what has been found in the UK Women’s Cohort Study [35].  Also 
the VITAL cohort [18] reports significant associations between high dose vitamin E and cancer in 
women as well as a study among cancer survivors [36], where only vitamin use, but not mineral, 
herbal or other types of supplement use, was associated with cancer.  In the VITAL cohort, the number 
of supplements consumed among women with a medical condition was higher than in men; however, 
the associations between supplement use and medical conditions were stronger in men [18].  It was 
suggested that women might use supplements to prevent illness, whereas men might start to take 
supplements after diagnosis.  In EPIC-Norfolk, the associations between supplement use and medical 
conditions were of similar strength for men and women, but data collected at later health examinations 
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will be able to answer important questions related to the onset of illness and the starting or stopping of 
supplement use.  Although the time between diagnosis and the start of the use of dietary supplements 
is also of importance since participants might make a change in their habits shortly after diagnosis, but 
return to their former habits after some time has passed [36], the surveys in EPIC-Norfolk might not be 
frequent enough to capture these changes. 
A limitation of our analysis is the stratification of results into SU+CLO and SU-CLO groups, since 
this is likely to have underestimated the heterogeneity among the SU-CLO subgroup.  A recent 
analysis of the Hertfordshire Cohort Study (HCS) used cluster analysis to describe five groups of SU; 
however, plant and fish oils were grouped together [15].  The aim of our analysis was to study possible 
confounding variables of participants consuming fish and CLO supplements.  SU+CLO reported more 
illnesses such as arthritis and less (symptoms of) cardiovascular disease and stroke, contrary to what is 
reported in the HCS [15].  A UK survey [5] and a survey among 65-98 year old Australians [24,25] 
however found similar associations to EPIC-Norfolk.  The data collected at later health examinations, 
will have to be taken into account before causal inferences between CLO and cardiovascular diseases 
can be made, especially since meta-analyses have not shown benefits [11,12].  The fact that CLO is 
positively associated with age, and that it is more likely to be taken on a daily basis, makes the 
SU+CLO subgroup of particular interest to investigate further since exposure to CLO is likely to have 
been for an extended period of time and follow-up time in this prospective cohort is by now two 
decades, contrary to trials.  The nutrients of these supplements are quantified in the ViMiS database 
where missing values for omega-3 fatty acids were completed, and units of measure were made 
compatible for food and supplement sources enabling the calculation of a ‘total nutrient exposure’ in a 
detailed way [8,37].  The wide range of endpoints collected will enable us to look at potential positive 
as well as harmful effects of CLO. 
5. Conclusions  
Significant socio-demographic associations were found in this study with weaker and fewer 
associations in SU+CLO than in SU-CLO group, especially among men.  Associations between 
supplement use and age, smoking, social class and education were strong, but not uniform across all 
SU or between sexes.  Participants, who had prevalent heart attack or stroke, were less likely to report 
CLO supplements; however, self-reported arthritis was associated with increased CLO use.  The 
differences we found between subgroups of SU provide important information that will be necessary 
for later endpoint analysis of this and other studies, since confounding by indication as well as lifestyle 
confounders will need to be taken into account dependent on the type of supplement consumed. 
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